Ledger.Open graph →
SEC Form D · filed June 8, 2022

Gemelli Biotech Corp

Offering
$20.0M
Sold
$18.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Raleigh, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Matthew Mitcho · Raleigh, NCExec · DirectorMark Pimentel · Raleigh, NCExec · DirectorJohn A. Neczesny · Raleigh, NCDirectorJames Laur · SAN DIEGO, CADirectorMatthew Mitcho · Raleigh, NCExec · DirectorMark Pimentel · Raleigh, NCExec · DirectorJohn A. Neczesny · Raleigh, NCDirectorJames Laur · SAN DIEGO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗